We investigated the mechanism of the anti-fibrotic effects of hepatocyte growth factor (HGF) in the kidney, with respect to its effect on connective tissue growth factor (CTGF), a down-stream, profibrotic mediator of transforming growth factor-β 1 (TGF-β 1 ). In wild-type (WT) mice with 5/6 nephrectomy (Nx), HGF and TGF-β 1 mRNAs increased transiently in the remnant kidney by week 1 after the Nx, returned to baseline levels, and increased again at weeks 4 to 12. In contrast, CTGF and α1(I) procollagen (COLI) mRNAs increased in parallel with HGF and TGF-β 1 during the early stage, but did not re-increase during the late stage. In the case of TGF-β 1 transgenic (TG) mice with 5/6 Nx, excess TGF-β 1 derived from the transgene enhanced CTGF expression significantly in the remnant kidney, accordingly accelerating renal fibrogenesis. Administration of dHGF (5.0 mg/kg/day) to TG mice with 5/6 Nx for 4 weeks from weeks 2 to 6 suppressed CTGF expression in the remnant kidney, attenuating renal fibrosis and improving the survival rate. In an experiment in vitro, renal tubulointerstitial fibroblasts (TFB) were co-cultured with proximal tubular epithelial cells (PTEC). Pretreatment with HGF reduced significantly CTGF induction in PTEC by TGF-β 1 , consequently suppressing COLI synthesis in TFB. In conclusion, HGF can block, at least partially, renal fibrogenesis promoted by TGF-β 1 in the remnant kidney, via attenuation of CTGF induction.
R enal fibrosis is the final common pathway for almost all forms of renal disease progressing to end-stage renal failure (1) . Renal fibrosis is characterized by atrophy and dilatation of the tubules and accumulation of extra-cellular matrix (ECM). The extent of renal fibrosis, even in primary glomerular diseases, is correlated more significantly with functional deterioration than is glomerular damage (2) .
Transforming growth factor-β 1 (TGF-β 1 ) is a well-characterized, pro-fibrogenic cytokine whose expression is markedly up-regulated, not only in most animal models of fibrotic disorders, including the remnant kidney model, but also in the human counterparts (3) . Administration of TGF-β 1 triggers events that promote fibrogenesis, including transcription of genes encoding ECM, inhibitors of matrix-degrading enzymes, and matrix binding integrin receptors (3) . The concentration of TGF-β 1 in plasma has been correlated with the development of several diseases, including cancer, atherosclerosis, autoimmune diseases, and end-stage renal diseases (ESRD) (4) . A recent study showed that, in humans, a C-509T genetic polymorphism in the TGF-β 1 gene was associated significantly with the plasma levels of TGF-β 1 , which may influence the clinical course of these diseases (4) . A part of the effect of TGF-β 1 may be modulated by other humoral factors, such as platelet-derived growth factor (PDGF), fibroblast growth factor-2 (FGF-2), and plasminogen activator inhibitor-1 (PAI-1). Among others, CTGF is a down-stream mediator of TGF-β 1 and modulates fibroblast cell growth and ECM production (5) . CTGF gene expression is induced strongly by TGF-β 1 , but not by other growth factors (6) . Protein synthesis is not required for CTGF gene expression promoted by TGF-β 1 , and a novel TGF-β 1 response element has been identified in the 5′ flanking sequence of the CTGF gene (7) . Typically, coordinate expression of TGF-β 1 and CTGF mRNAs has been observed during wound repair.
Hepatocyte growth factor (HGF) is a pleiotropic protein isolated originally as a potent mitogen for hepatocytes (8) and is known to have mitogenic, motogenic, and morphogenic effects on the epithelial cells of a number of organs (9) , including the kidney. HGF is expressed mainly in interstitial cells, endothelial cells, and macrophages in the normal kidney, whereas its receptor, c-Met, is present on the surface of proximal tubular epithelial cells. Following specific damage, such as partial hepatectomy, HGF mRNA levels increase, not only in the liver, but also in other organs, and circulating HGF derived from those organs rescues the damaged site (10) . Similarly, following heminephrectomy or an ischemic insult, HGF expression is augmented markedly, not only in the kidney but also in distant organs such as the liver, spleen, and lungs (10) . Administration of recombinant HGF to rats with an acute ischemic insult to the kidney enhances the functional and morphological recovery of injured tubular epithelium (11) . Recently, it has been reported that HGF also can prevent renal fibrogenesis in spontaneously nephrotic mice (12) , in which HGF was assumed to counteract against TGF-β 1 . The mechanism of the anti-fibrotic effects of HGF, however, was not described in detail.
Renal mass reduction (greater than 50%) in rats generally leads to the development of glomerulosclerosis and interstitial fibrosis in the remnant kidney, resulting in chronic progressive renal failure. In this situation, up-regulated expression of TGF-β 1 has been demonstrated to play a major role in renal fibrogenesis. In contrast, renal mass reduction in mice seldom causes parenchymal damage in the remnant kidney, and its cardinal features have never been examined in detail (13) . In this study, therefore, by using mice resistant and susceptible to progressive renal fibrosis after 5/6 Nx, we determined a possible mechanism through which HGF prevents renal fibrogenesis promoted by TGF-β 1 , and demonstrated the efficacy of its anti-fibrotic action.
METHODS

Design of the animal studies
Five-week-old male TGF-β 1 transgenic (TG) mice (14) , line 25, and male wild-type (WT) mice (C57Bl/6J X CBA, F2) were used in these experiments. All the TG mice are male because the TGF-β 1 transgene, under the control of albumin promoter, is integrated into the Y chromosome. Male TG mice were maintained by continuous breeding with female F1 C57Bl/6J X CBA mice. The plasma levels of TGF-β 1 are 2-3 times higher than those seen in age-matched WT mice, and this TG mouse lives a normal life span, with occasional exceptions (14) . Nx mice (5/6) were generated by the ablation of 2/3 of the mass of the right kidney and heminephrectomy of the left kidney 1 week later. TG mice (n=57) and WT mice (n=103) received 5/6 Nx, which enabled us to observe alterations in the remnant kidney. The mice were killed at multiple time points (n=5-7 at each time point) up to 12 weeks after the Nx, to collect remnant kidneys for mRNA extraction and histopathological analysis as described below. The entire kidneys obtained from the heminephrectomies were used as the control samples at week 0.
To examine the effects of exogenous HGF on progressive renal fibrogenesis and the survival rate of TG mice with 5/6 Nx, we administered recombinant human deleted HGF (dHGF) (a generous gift from Toshiya Kobayashi, Life Science Research Institute, Snow Brand Milk Products Co. Ltd., Tochigi, Japan). TG mice in the treated group (n=34) were given twice-daily subcutaneous injections of dHGF (5.0 mg/kg/day) for 4 weeks from weeks 2 to 6 after the Nx (NxTG + dHGF), whereas the control TG mice (n=58) were given subcutaneous injections of an identical volume of phosphate-buffer saline (PBS) (NxTG + PBS). dHGF administration did not decrease the serum level of albumin (15) . Additional mice were included in this experiment and were killed at 2, 6, and 8 weeks after the Nx for sample collection (n=6 at each time point), but were excluded from the survival analysis. These experiments were approved by the Animal Research Committee of Saitama Medical College.
Histopathological analysis
Small pieces of the remnant kidneys were placed in 4% paraformaldehyde-PBS overnight and processed for light microscopy by embedding in paraffin and staining with hematoxylin eosin (HE) and Masson's trichrome (MT), and for in situ hybridization by rinsing in serial concentration sucrose solutions and snap-freezing. Fibrotic areas in blue in the MT-stained sections were measured quantitatively by using a computer-assisted image analyzer (Mac SCOPE Ver. 2.5, Mitani Corp., Fukui, Japan).
Immunohistochemical staining and in situ hybridization (ISH)
CTGF protein and mRNA distribution in the remnant kidney were investigated by immunohistochemistry and ISH. After deparaffinization, endogenous peroxidase was inactivated in 0.3% H 2 O 2 /methanol and any nonspecific reaction was blocked with 5% bovine serum albumin (BSA)-PBS (5% BSA, 0.02% Tween20, 0.02% NaN 3 in PBS). The sections were incubated overnight at 50°C with rabbit polyclonal anti-CTGF antibody (16) , washed extensively and then incubated with biotinylated goat anti-rabbit IgG by using streptavidin-biotin-peroxidase kits (VECTASTAIN, Vector Laboratories, Inc., Burlingame, CA). Visualization of the antigen was performed with 3, 3′-diaminobenzidine and H 2 O 2 . Counter-staining was performed with hematoxylin. Sections stained with the secondary antibody alone were used as the negative controls.
ISH was performed on 4 µm cryostat sections as described previously (17) . Antisense and sense cRNA probes were generated from CTGF cDNA (202 bp, 731 to 932 corresponding to mouse CTGF; gb:M70642=) (18) , generated in our laboratory by reverse transcription-polymerase chain reaction (RT-PCR). The hybridization solution contained 50% deionized formamide, 10% dextran sulfate, 1× Denhardt's solution, 600 mM NaCl, 10 mM DTT, 0.25% SDS, 250 µg/ml E. coli tRNA, and ~0.5 µg/ml digoxigenin-labeled cRNA probe. Hybridization solution (50 µl) was placed on each section, which was then covered with parafilm and incubated at 50°C overnight in a humidified chamber. After hybridization, the parafilm was removed by washing with 5× SSC briefly and with 50% formamide, 2× SSC for 30 min at 50°C. RNase A treatment (10 µg/ml) was performed at 37°C for 30 min. The sections were washed with 2× SSC and 0.2× SSC for 15 min twice at 50°C. Hybridized digoxigenin-labeled probes were detected by a Digoxigenin Detection Kit (Roche Diagnostics, Indianapolis, IN). At the step of color development, 1 mM levamisole was added to the developing solution. After the color reaction, the slides were rinsed with 10 mM Tris-HCl; pH 8.0, 1 mM EDTA and mounted without counterstaining.
Cell culture
A cultured cell line of murine renal proximal tubular epithelial cells (PTEC) was a generous gift of Takeshi Sugaya (Discovery Research Laboratory, Tanabe Seiyaku Co., Ltd., Osaka, Japan). PTEC and a murine tubulointerstitial fibroblast cell line (TFB) (19) were maintained in growth media [10% fetal calf serum (FCS), 100 U/ml penicillin, 100 µg/ml streptomycin in Dulbecco's Modified Eagle's Medium (D-MEM)]. TFB were seeded (15,000 cells/cm 2 ) onto sixwell plates, whereas PTEC were seeded (30,000 cells/cm 2 ) separately onto cell culture inserts (Falcon Cell Culture Inserts, 0.4 µm pore size, Becton Dickinson, Franklin Lakes, NJ). On day 1, the medium was changed to K-1 medium (50:50 Ham's F-12/D-MEM with 5 µg/ml transferrin, 5 µg/ml insulin, and 5 × 10 −8 M hydrocortisone) to make the cultured cells quiescent. Concomitantly, the inserts containing PTEC were put into the wells where the TFB grew. On day 4, in some experiments, these cells were pretreated with 100 ng/ml of recombinant human HGF (R&D Systems, Minneapolis, MN) overnight, before stimulation. On day 5, the medium was changed again to fresh K-1 medium containing 3.0 ng/ml of rhTGF-β 1 (R&D Systems) alone or in combination with neutralizing anti-CTGF antibody or 20 ng/ml of rhCTGF (16) . K-1 medium alone was used as the negative control. At 30 min and 2 h after the stimulation with TGF-β 1 , total cellular protein and RNA were extracted from PTEC on the inserts, as described below, to evaluate the effects of HGF on Smad3 phosphorylation and CTGF gene expression in PTEC, respectively. To investigate COLI synthesis by TFB in the wells, the culture supernatant was collected at 24 h after stimulation.
Ribonuclease protection assay (RPA)
The samples from the remnant kidneys and cultured cells were homogenized in TRIzol (GIBCO BRL, Grand Island, NY), and total RNA was harvested according to the manufacturer's instructions. RPA was performed as described previously (20) (21) (22) . In brief, 32 P-labeled antisense cRNA probes were synthesized by in vitro transcription by using the linearized plasmids bearing each cDNA. Total RNA (10 µg) was hybridized with the target cRNA probe, along with a glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antisense probe, at 45°C overnight. The unhybridized probes were digested with RNase A (1.2 µg/ml) and RNase T1 (120 units/ml) for 60 min at 30°C, and the RNases were digested with proteinase K (0.45 µg/ml) at 37°C for 30 min. After phenol/chloroform extraction, the hybridized probes were precipitated with ethanol and were heat-denatured for electrophoresis on 6% polyacrylamide gels. The dried gels were exposed to X-ray films at -70°C to detect the expression of each mRNA. For quantification of mRNA expression, the bands on the autoradiographs were analyzed by computerized densitometry by using NIH Image software (Ver. 1.62, Division of Computer Research and Technology, NIH, Bethesda, MD). Template strands for in vitro transcription were as follows: GAPDH (115 bp, 673 to 787 corresponding to rat GAPDH;gb:M17701=) and TGF-β 1 (255 bp, 500 to 754 corresponding to rat TGF-β 1 ;gb:X52498=) were generous gifts from Tadashi Yamamoto (Niigata University, Niigata, Japan). CTGF, HGF (252 bp, 963 to 1214 corresponding to rat HGF;gb:E03330=), TGF-β 2 (154 bp, 1303 to 1456 corresponding to mouse TGF-β 2 ;gb:X57413), TGF-β 3 (200 bp, 656 to 855 corresponding to mouse TGF-β 3; gb:M32745), and α1(I) procollagen (285 bp, 625 to 909 corresponding to mouse α1(I) procollagen; gb:M14423) (23) were cloned by RT-PCR in this laboratory.
Western blot analyses
Western blotting was performed as described previously (24) . Cultured cells were washed in PBS and then lysed in 200 µl of 1% Nonidet P-40, 25 mM Tris-HCl, 150 mM NaCl, 10 mM EDTA, pH 8.0, containing a 1:50 dilution of a protease inhibitor cocktail (P2714, Sigma) for 30 min on ice. Samples were centrifuged at 14,000 g for 5 min to pellet cell debris. Samples (40 µg) were mixed with SDS-PAGE (SDS-PAGE) sample buffer, boiled for 5 min, electrophoresed on a 10% SDS polyacrylamide gel, and electroblotted onto Hybond-ECL nitrocellulose membrane (Amersham Biosciences, Piscataway, NJ). The membrane was blocked in PBS containing 5% nonfat milk powder and 0.02% Tween 20. To detect phosphorylated Smad3 (p-Smad3) and total Smad3, the membrane was incubated for 1 h with rabbit polyclonal antibody to p-Smad2/3 (Santa Cruz Biotechnology, Santa Cruz, CA) and the one to Smad3 (Upstate Biotechnology, Lake Placid, NY), respectively. After washing, the membrane was incubated with a 1:10,000 dilution of peroxidase-conjugated goat anti-rabbit IgG in PBS. The blot was then developed by using the ECL detection kit (Amersham Biosciences) to produce a chemiluminescence signal, which was captured on X-ray film.
Indirect enzyme-linked immunosorbent assay (ELISA)
Indirect ELISA was performed as described previously (19) . In brief, 96-well ELISA plates (MAXISORP, Nalgenunc International, Rochester, NY) were coated with the culture supernatant by incubating for 1 h at 37°C. After coating, the plates were washed with 0.15 M NaCl and 0.05% Tween 20 washing solution. After washing, the plates were blocked with 10% nonfat milk and 0.1% Tween 20 in PBS for 1 h at room temperature. After blocking, the plates were incubated with 1:3000 dilution of rabbit polyclonal anti-COLI antibody (Chemicon International, Temecula, CA) in blocking buffer. After incubation with the primary antibody, the plates were incubated with a 1:3000 dilution of alkaline phosphatase-conjugated goat anti-rabbit IgG. Disodium p-nitrophenyl phosphate was used as the substrate. After color development, the absorbance was measured with an ELISA autoreader at 405 nm. A standard curve of collagen concentration was made by measurement of authentic collagen serial dilution solution.
Statistical analysis
All values are expressed as mean ± SD. ANOVA with subsequent Bonferroni/Dunnett's test was used to determine the significance of difference in multiple comparisons. Mann-Whitney U-test was used to compare the means of two groups. Kaplan-Meier analysis with log-rank test was used to compare the cumulative survival rates of the NxTG + dHGF and NxTG + PBS groups. Values of P<0.05 were considered statistically significant.
RESULTS
Expression of fibrosis-related genes and histopathology in WT mice with 5/6 Nx
First, we examined changes in the mRNA levels of molecules related to fibrogenesis, for example, TGF-β 1 , HGF, CTGF, and α1(I) procollagen, in the remnant kidneys of NxWT mice. At 8 to 24 h after the final Nx, there were significant increases in all the mRNAs examined (Fig.  1A-D) . Expression of these mRNAs decreased gradually to basal levels by weeks 2 to 4. However, the expression of TGF-β 1 (Fig. 1A) and HGF (Fig. 1B) mRNAs started increasing again and reached another peak at week 8. In contrast, the expression of CTGF (Fig. 1C) and α1(I) procollagen (Fig. 1D ) mRNAs remained at basal levels until week 12. Light microscopic evaluation of the remnant kidney tissues revealed that there were no significant tubulointerstitial alterations in NxWT mice at week 12 ( Fig. 1E-a) , as in the sham-operated WT mice (Fig. 1E-b) .
Expression of fibrosis-related genes and histopathology in TG mice with 5/6 Nx
The expression of α1(I) procollagen mRNA increased significantly in the remnant kidneys of NxTG mice at 8 weeks after the final Nx (Fig. 2D) . This increased level remained until the end of the experiment. In the remnant kidneys of NxTG mice, HGF gene expression was similar to the one of the NxWT mice (Fig. 2B) ; however, the levels of expression of TGF-β 1 ( Fig. 2A) and CTGF (Fig. 2C ) mRNAs were significantly higher than those of NxWT mice. The kidney tissues of NxTG mice at day 0 showed no significant alterations in the interstitium (Fig. 2E-a) . Subsequently, the kidney tissues of NxTG mice at week 12, in contrast to the NxWT mice, showed prominent interstitial expansion and increased ECM deposition (Fig. 2E-b ). There were few significant, spontaneous tubulointerstitial alterations in the sham-operated, control TG mice by this time point of their natural lives (data not shown). Immunohistochemical staining and ISH for CTGF in the remnant kidneys of NxTG mice at week 4 revealed that the CTGF protein and mRNA were localized in the tubular epithelial cells, as well as in the glomerular visceral and parietal epithelial cells (Fig. 2F-a and c) . No signals of CTGF protein were observed in NxWT mice because the expression level of CTGF even in the glomerular epithelial cells, which are known to be potent producers of CTGF, in NxWT mice was likely lower than the detection limit of our immunohistochemistry (Fig. 2 F-b) . In the case of ISH, marked signals of CTGF mRNA were observed restrictedly in the glomerular visceral epithelial cells in NxWT mice (data not shown). There were no nonspecific, background signals in the negative controls of either experiment (Fig. 2 F-d) .
Cell culture
To determine the effects of HGF on CTGF gene expression in tubular epithelial cells stimulated by TGF-β 1 , an experiment was performed in vitro by using PTEC co-cultured with TFB. Pretreatment with HGF did not affect the expression of the CTGF gene in PTEC, compared with the control (Fig. 3A) . CTGF gene expression increased significantly in PTEC in response to TGF-β 1 treatment. However, pretreatment with HGF attenuated significantly CTGF gene expression induced by TGF-β 1 in PTEC (Fig. 3A) . In this experiment, CTGF expression in TFB stimulated with TGF-β 1 was negligible (data not shown), a finding that was also cited in another laboratory (25) and was possibly due to spontaneous transformation during in vitro culture of TFB. Synthesis of COLI protein was increased in TFB by TGF-β 1 stimulation (Fig. 3B) . COLI synthesis in TFB in the co-culture system was reduced significantly by treatment with neutralizing anti-CTGF antibody (Fig. 3B) , showing that COLI synthesis in TFB was mediated, at least partially, by secreted CTGF. The increase in COLI protein synthesis was inhibited significantly by HGF pretreatment, through attenuation of CTGF induction in PTEC, which was rescued by co-administration of rhCTGF (Fig. 3A, B) . Western blot analyses demonstrated that TGF-β 1 could phosphorylate Smad3 in PTEC regardless of pretreatment with HGF (Fig. 3C) , suggesting that the effect of HGF on TGF-β 1 action were at subsequent, downstream levels in PTEC.
Effects of dHGF Administration in TG mice with 5/6 Nx
Gene expression of TGF-β 1 , TGF-β 2 , and TGF-β 3 in the remnant kidneys of the NxTG+dHGF group was similar to that of the NxTG+PBS group (data not shown). In contrast, administration of dHGF reduced significantly the expression of the CTGF gene in the remnant kidneys of the NxTG+dHGF group at week 6 after the final Nx (Fig. 4A) , thereby resulting in a decrease in α1(I) procollagen gene expression (Fig. 4B) . The remnant kidneys of both groups showed only slightly widened interstitium at week 2 (Fig. 4 C-a and b) . The remnant kidneys of the NxTG+PBS group at week 6 developed significant tubular atrophy, interstitial expansion, and increased ECM deposition (Fig. 4 C-c and d) , in the remnant kidneys of the NxTG+dHGF group, however, such histopathological alterations were attenuated significantly (Fig. 4 C-e and f) . Quantitative analysis of interstitial ECM deposition by light microscopy demonstrated that the fibrosis area in blue in the MT-stained sections was decreased markedly in the NxTG+dHGF group (3.59±0.99%) compared with the NxTG+PBS group (19.51±4.25%) at week 6 (Fig. 4D) . The survival rate was improved significantly in the NxTG mice treated with dHGF (Fig. 4E) , perhaps because of the attenuated renal fibrosis.
DISCUSSION
In this study, we demonstrated that HGF could counteract TGF-β 1 and prevent renal interstitial fibrogenesis in mice with 5/6 Nx through attenuation of CTGF induction. The increases in expression of TGF-β 1 , HGF, and α1(I) procollagen mRNAs in the remnant kidney during the early stage (~1 week after the final Nx) are believed to reflect regeneration following the acute insult of the Nx. Indeed, in this period, there was no progression of interstitial fibrosis in the remnant kidney. Increased HGF in response to the Nx promotes renal regeneration by enhancing cell growth and promoting morphogenesis of the renal tissue (11, 26) . TGF-β 1 also is induced to repair the damage, and it promotes production of ECM proteins (fibronectin, collagens, and proteoglycans) to seal the wounds (3).
Expression of the genes examined in this study decreased gradually to baseline levels by week 2, when the turbulent early stage had calmed down. Subsequently, expression of HGF and TGF-β 1 mRNAs increased again significantly during weeks 8 to 12. This biphasic change in expression of growth factor genes in the remnant kidney was found also in rats, and the mechanism remains to be elucidated (27) . Expression of the α1(I) procollagen gene did not parallel them during the subsequent late stage. One of the possible hypotheses arising from these findings is that, in the remnant kidneys of NxWT mice, endogenous HGF, at least at the late stage, likely prevents renal fibrogenesis promoted by TGF-β 1 . Consistent with our hypothesis, by using a rat 5/6 Nx model and anti-HGF neutralizing antibody, Dworkin and his colleagues demonstrated that endogenous HGF could suppress renal fibrosis (27) . In their study, HGF was shown to increase matrix metalloproteinase-9 (MMP-9) expression markedly and to decrease expression of tissue inhibitors of matrix metalloproteinase-1 (TIMP-1) and TIMP-2, the endogenous inhibitors of MMPs, promoting ECM degradation and reducing net ECM deposition in the remnant kidney. Some investigators suggested that HGF decreases in response to the increase in TGF-β 1 expression during the progression of chronic renal failure, because TGF-β 1 inhibits transcription of the HGF gene. However, administration of HGF could counteract the pro-fibrotic actions of TGF-β 1 and enhance remodeling of renal tissues, including ECM degradation, in defense against epithelial apoptosis and endothelial cell proliferation in the fibrosing kidney (12, 28) . Although the mechanisms of these reciprocal actions between HGF and TGF-β 1 have not been explained in detail, these results suggest that HGF is a potent anti-fibrogenic factor and can activate the ECM degradation pathway to block organ fibrogenesis, at least in the remnant kidney in rats.
In this study, expression of TGF-β 1 mRNA was not inhibited by endogenous HGF in the remnant kidneys of NxWT mice, or vice versa. As the principal producers of TGF-β 1 , interstitial fibroblasts and macrophages have been demonstrated to be of importance in renal fibrogenesis. HGF cannot inhibit directly the production of TGF-β 1 in those cells, because they do not express c-Met, an HGF receptor molecule. Furthermore, because COLI expression was lowered and remained at the baseline level in the remnant kidneys of NxWT mice, the anti-fibrotic action of HGF was not dependent on the ECM degradation pathway in our model. To investigate the interaction between TGF-β 1 and HGF at the late stage in the remnant kidney, we focused on the changes in expression of CTGF mRNA. CTGF is a down-stream, pro-fibrotic mediator of TGF-β 1 described in detail above. The CTGF mRNA level increased at 8 h after the final Nx, then decreased and remained at the baseline level until the end of experiment, resulting in no significant renal fibrosis. Therefore, it is suggested that one of the possible primary determinants of the progression of renal fibrosis is likely to be CTGF gene expression in the remnant kidney.
Alb/TGF-β 1 TG mice express the TGF-β 1 transgene exclusively in the liver (29) . They develop pathologic lesions in some tissues spontaneously several months after birth, for example, hepatic fibrosis, myocarditis, and renal disease. In the present study, removal of 5/6 kidney induced advanced renal fibrosis reproducibly in TG mice by week 12 after the final Nx (17 weeks old). The relative potency of TGF-β 1 in the remnant kidney was supposed to predominate over endogenous HGF, resulting in the up-regulation of CTGF gene expression followed by an increase in COLI gene expression. We showed positive immunostaining for CTGF protein in the tubular epithelial cells in the remnant kidneys of NxTG mice at week 4. Tubular epithelial cells can modulate the biological behaviors of adjacent interstitial fibroblasts in the kidney through paracrine mechanisms (30) . Renal insults that result in proximal tubule injury likely perturb this paracrine interaction, thereby culminating in excessive fibroblast proliferation and interstitial fibrosis. Considering these findings, we proposed the hypothesis that the reciprocal balance between the effects of TGF-β 1 and HGF within the tubular epithelial cells may be able to determine the CTGF expression level and overall renal fibrogenesis.
To prove this hypothesis, a series of experiments were performed in vitro. In these studies, PTEC expressed the CTGF gene, and expression of the CTGF gene was induced significantly by TGF-β 1 treatment. We showed also that such a stimulatory effect of TGF-β 1 was reduced when PTEC were pretreated with HGF. In the co-culture experiments with anti-CTGF antibody, it was revealed that the important determinants of COLI synthesis in TFB were not only TGF-β 1 per se, but also CTGF derived from PTEC, which also were stimulated by TGF-β 1 . Counteractions of TGF-β 1 and HGF within PTEC could affect COLI expression in TFB by regulating the CTGF induction in PTEC, which was consistent with our observations in vivo, described above. The in vitro finding that co-administration of rhCTGF could compensate the effect of HGF pretreatment on PTEC likely confirms our hypothesis. Elevating intracellular cyclic adenosine monophosphate levels, or treatment with tumor necrosis factor-α, was found to suppress the TGF-β-induced expression of CTGF in fibroblasts (31, 32) , but there have been no data reported concerning the interplay of TGF-β 1 and HGF.
TGF-β signals are transmitted through the phosphorylation of the tumor-suppressor Smad proteins by receptor serine/threonine kinase (RS/TKs), leading to the nuclear accumulation and transcriptional activity of Smad proteins (33) . TGF-β-induction of CTGF is dependent on Smad3 and Smad4 (34) . In contrast to the TGF-β family ligands, HGF signals responses through transmembrane receptor tyrosine kinases (RTKs). Phosphorylation of Smad proteins is presumed to play a pivotal role in mediating cross talk between the RS/TKs and RTKs (35, 36) , but the mode of action is inconsistent and varies in each report (33) . In any cases, TGF-β activates the Smad cascade rapidly, resulting in Smad/DNA interactions within minutes, so this theory may be inadequate to explain the pretreatment effect. We found that pretreatment with HGF did not affect Smad3 phosphorylation induced by TGF-β 1 in PTEC, suggesting that an interplay between these growth factors is likely at subsequent, downstream levels. TGF-β also induces a member of the AP-1 family c-jun. A recent study suggests that interactions between Smad3 and c-Jun result in the reduction of Smad3/DNA interaction, effectively a negative feedback mechanism counteracting Smad-driven gene transactivation (37) . In rat hepatocytes, HGF increased the expression of c-jun mRNA in a concentration-dependent manner (38) , so we assume that the c-jun gene expression induced by HGF pretreatment leads to inhibition of the transcription of the CTGF gene via a Smad3/c-Jun interaction. Details of the molecular regulatory mechanism of HGF blocking the CTGF gene expression induced in tubular epithelial cells by TGF-β 1 need to be clarified with further experiments.
NxTG mice were given a large amount of either dHGF or PBS for a 4-week period before significant renal fibrosis developed. Daily injections of dHGF decreased expression of CTGF and COLI mRNAs in the remnant kidney more than was found in the PBS-injected control mice. These findings also were consistent with our observation in vitro. With regard to histological analysis, the area of interstitial fibrosis was markedly narrowed in the dHGF-injected mice, thereby improving the survival rate of NxTG+dHGF mice. TGF-β gene expression was not down-regulated in the remnant kidney by dHGF injections, and the plasma level of TGF-β 1 remained high in the NxTG+dHGF mice. Therefore, exogenous HGF attenuated the COLI gene expression in the remnant kidney in this experiment, not via a reduction in TGF-β gene expression but via a blockade of CTGF induction. Although we cannot exclude another possibility that HGF interferes with activation of latent TGF-β, especially in vivo, our results in vitro suggest that HGF interferes with the actions of TGF-β at downstream levels, below Smad3 phosphorylation by TGF-β. A few reports reveal that CTGF is essential not only for induction of collagen synthesis by TGF-β 1 but also for anchorage-independent growth of fibroblasts, by modulating cyclin-dependent kinase activities. Therefore, HGF also could block fibroblast proliferation induced by CTGF, resulting in prevention of interstitial cell increment.
Although the molecular mechanisms of interstitial fibrogenesis have not been described fully, accumulation of ECM deposition following excess expression of TGF-β is thought to play a pivotal role. Administration of HGF could block the expression of CTGF mRNA induced by TGF-β 1 in renal tubular epithelial cells. CTGF, rather than TGF-β 1 , likely serves as a specific target for selective intervention in the process involved in connective tissue formation during wound repair or tissue fibrogenesis, because the biological actions of TGF-β 1 are complex and affect a number of different cell types. Our observation that HGF replacement therapy attenuated renal fibrogenesis by lowering CTGF expression is intended to lead to the development of new therapeutic approaches to the control of fibrotic disorders in humans.
In conclusion, the pro-fibrotic effects of TGF-β 1 were exerted through expression of the CTGF gene in PTEC, and HGF can block such CTGF induction, resulting in the anti-fibrotic effects. In a 5/6 Nx mouse model, as well as in vitro, this anti-fibrotic effect of HGF against TGF-β 1 was demonstrated to be mediated at least partially by a suppression of CTGF gene expression in the tubular epithelial cells, induced by TGF-β 1 . Thus, HGF administration potentially may be useful for the treatment of patients with a variety of progressive kidney diseases. Ribonuclease protection assay revealed that expression of CTGF mRNA was reduced significantly in the remnant kidneys of NxTG+dHGF mice after dHGF administration (at week 6 after the Nx) (A). HGF treatment reduced CTGF expression significantly, resulting in a decrease in collagen expression in the remnant kidneys of NxTG+dHGF (B). *P<0.05 vs. NxTG+PBS mice. Histology of the remnant kidney tissues of NxTG+PBS mice and NxTG+dHGF mice (C). The remnant kidneys at week 2 after the Nx (before dHGF administration) showed slightly widened interstitium (C-a, b) . At week 6, the remnant kidney tissues of NxTG+PBS mice after PBS administration showed tubular atrophy, interstitial expansion, and increased matrix accumulation (C-c, d) ; however, in the remnant kidneys of NxTG+dHGF mice, such alterations were attenuated significantly (C-e, f). (Upper row; H.E. staining, Mo.: 20×, lower row; M.T. staining, Mo.: 4×) Quantitative analysis of interstitial fibrosis by light microscopy (D). The area of fibrosis in blue in the MT stained section was measured quantitatively by using a computer-assisted image analyzer. This revealed that the dHGF administration prevented interstitial fibrogenesis significantly.
# P<0.05 vs. NxTG+PBS mice, § P<0.05 vs. NxTG mice at week 2. Life Survival of the 5/6 NxTG mice in NxTG+PBS and NxTG+dHGF (E). Life-table analyses are presented as Kaplan-Meier plots. The survival rate was improved significantly in the 5/6 NxTG mice treated with dHGF (NxTG+dHGF).
